Position in RLMD
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$3,145,349
+$2,996,267 QoQ
Shares Held
451,918
+1364.1% QoQ
Ownership
0.431%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ADAR1 Capital Management, LLC holds $1,363,006,285 across 212 Biotechnology names. RLMD ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,394,019 | $155,224,015 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
994,119 | $104,780,142 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,285,906 | $91,019,596 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,679,010 | $66,546,608 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
914,699 | $48,222,931 | |
| 6 | CYTK |
Cytokinetics Inc
|
632,556 | $41,691,765 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,139,331 | $41,380,501 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
1,871,455 | $35,931,936 |
All Filings in RLMD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,145,349 | 451,918 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $149,082 | 30,866 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $78,000 | 130,000 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $151,803 | 50,601 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,794 | 601 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $242,608 | 58,601 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||